Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study)

Yang, Y; Zhu, L; Cheng, Y; Liu, ZC; Cai, XY; Shao, JC; Zhang, M; Liu, J; Sun, YF; Li, Y; Yi, J; Yu, BT; Jiang, HJ; Chen, HZ; Yang, H; Tan, LJ; Li, ZG

Li, ZG (通讯作者)，Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, 241 West Huaihai Rd, Shanghai 200030, Peoples R China.

BMC CANCER, 2022; 22 (1):

Abstract

Background: Preoperative chemoradiotherapy (CRT) with CROSS regimen has been the recommended treatment for locally advanced esophageal squamous cell c......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索